Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-08-15Clinical Trial Update: CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X) [Phase 2]
A Phase 2 trial (CAPE-X) evaluating CAPEcitabine as adjuvant therapy for pancreatic cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-08-13Clinical Trial Update: Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors [Phase 1, Phase 2]
A phase 1/2 trial evaluating TNG348 alone and in combination with a PARP inhibitor for BRCA1/2-mutant or HRD-positive solid tumors has been …
-
CLINICAL_TRIALS withdrawal · 2024-06-21Clinical Trial Update: Pilot Study of 89-Zr Panitumumab in Pancreas Cancer [Phase 1]
A Phase 1 pilot study of Zirconium-89 labeled Panitumumab for pancreatic cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-06-13Clinical Trial Update: GI Organ Tracking Via Balloon Applicators [NA]
A clinical trial evaluating GI organ tracking via balloon applicators sponsored by Washington University School of Medicine has been withdra…
-
CLINICAL_TRIALS withdrawal · 2024-06-12Clinical Trial Update: Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care [NA]
The clinical trial evaluating acupuncture and Chinese herbal medicine in palliative care for cancer patients has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2022-04-01Clinical Trial Update: Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases [Phase 2, Phase 3]
A study evaluating anti-CEA CAR-T plus chemotherapy versus chemotherapy alone in pancreatic cancer with liver metastases has been withdrawn …
-
CLINICAL_TRIALS withdrawal · 2021-05-07Clinical Trial Update: An Extension Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer [Phase 3]
An extension phase 3 trial of methylnaltrexone bromide in advanced pancreatic cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-05-07Clinical Trial Update: A Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer [Phase 2, Phase 3]
A study of methylnaltrexone bromide (MNTX) in advanced pancreatic cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-03-19Clinical Trial Update: Eus-guided Cryothermal Ablation in Stage III Pancreatic Adenocarcinoma [Phase 3]
Phase 3 trial of eus-guided cryothermal ablation in pancreatic adenocarcinoma was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-06-26Clinical Trial Update: Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma [Phase 4]
A Phase 4 trial investigating gut microbiome modulation to enhance checkpoint inhibitor efficacy in pancreatic cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-02-15Clinical Trial Update: A Pilot Study to Evaluate the Efficacy of ITDD vs. CMM in the Treatment of Pancreatic Cancer Pain [NA]
This clinical trial update notes that the pilot study comparing intrathecal drug delivery (ITDD) to conventional medical management for panc…
-
CLINICAL_TRIALS withdrawal · 2018-07-12Clinical Trial Update: Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene [Phase 2]
A phase 2 trial evaluating mitomycin-C in patients with advanced or recurrent pancreatic cancer harboring a BRCA2 mutation was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-02Clinical Trial Update: Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) [Phase 1, Phase 2]
The NivoPlus trial evaluating nivolumab plus chemotherapy in various advanced cancers has been terminated (Phase 1/Phase 2).
-
CLINICAL_TRIALS withdrawal · 2018-05-17Clinical Trial Update: Phase I Study Evaluating the Treatment of Patients With Locally Advanced Pancreatic Cancer With Carbon Ion Radiotherapy: The PHOENIX-01 Trial [NA]
The PHOENIX-01 Phase I trial evaluating carbon ion radiotherapy for locally advanced pancreatic cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-12-06Clinical Trial Update: Registry for Pancreatic Cancer
The clinical trial registry for pancreatic cancer (NCT03001505) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-10-27Clinical Trial Update: Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer [Phase 1]
A Phase 1 trial evaluating sildenafil for fatigue in pancreatic cancer (and cholangiocarcinoma) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors [Phase 1]
A Phase 1 trial evaluating CT-011 and a p53 genetic vaccine for advanced solid tumors was withdrawn; the study encompassed breast cancer, co…
-
CLINICAL_TRIALS withdrawal · 2017-04-24Clinical Trial Update: Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
A Phase 1 clinical trial of talazoparib in patients with advanced or metastatic solid tumors unsuitable for surgery and with liver or kidney…
-
CLINICAL_TRIALS withdrawal · 2017-03-06Clinical Trial Update: Endoscopic Pancreatic Duct Stenting for Relief of Obstructive Pain in Patients With Pancreatic Cancer [Phase 1, Phase 2]
A clinical trial evaluating endoscopic pancreatic duct stenting to relieve obstructive pain in pancreatic cancer patients has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2017-02-23Clinical Trial Update: Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer [NA]
This clinical trial update notes the withdrawal of a Phase II study evaluating first-line stereotactic body radiotherapy for non-metastatic …
-
CLINICAL_TRIALS withdrawal · 2017-02-14Clinical Trial Update: Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures [NA]
A clinical trial comparing 19- and 22-gauge needles for core tissue procurement during EUS-guided procedures in pancreatic cancer has been w…
-
CLINICAL_TRIALS withdrawal · 2017-01-26Clinical Trial Update: Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery
A clinical trial assessing the EnLight and LightPath imaging systems for gastrointestinal tumor surgery has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-07Clinical Trial Update: Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic Cancer [NA]
Compassionate single-subject use of pamrevlumab (FG-3019) for locally advanced, unresectable pancreatic cancer has been withdrawn from the s…
-
CLINICAL_TRIALS withdrawal · 2016-10-06Clinical Trial Update: Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for Adenocarcinoma [Phase 2]
A Phase 2 safety trial of adjuvant gemcitabine after laparoscopic distal pancreatectomy for pancreatic adenocarcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-09-13Clinical Trial Update: Head to Head Comparison of Two Needles EUS Guided FNB [NA]
A clinical trial comparing two needles for endoscopic ultrasound-guided fine-needle biopsy in pancreatic cancer patients was withdrawn.